European Pharmaceutical Review

JULY 7, 2022

He then had a one-year stint at Merck Research Laboratories as Director of Clinical Research for Clinical Hepatology before returning to Bristol Myers-Squibb from 2010-2015. ” Since September 2021, Dr Hughes has been Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals, based in Boston.

Medical 98

Medical Medicine Pharmaceutical Leads 98

pharmaphorum

OCTOBER 28, 2022

Nina Pinwill leads the commercial operations function within the Commercial Medicines Directorate at NHS England. Alongside his work as a recognised author, speaker, moderator and industry advisor, he founded the industry-leading publication pharmaphorum in 2009. She is an SME in market access, rare disease and biosimilars.

Medicine 122

Medicine Management Marketing Leads 122

European Pharmaceutical Review

AUGUST 8, 2022

Dan Miller of Walden Macht & Haran, lead counsel to Streck, commented on the decision: “The jury has spoken. million) in 2015 , also for knowingly underpaying Medicaid rebates. Eli Lilly knowingly violated the False Claims Act and defrauded the Medicaid Program of $61 million in taxpayer money. . million) and Cephalon ($7.5

Manufacturing 98

Manufacturing Pharmaceutical Pharma Leads 98

European Pharmaceutical Review

JANUARY 25, 2023

Collaboration between Vertex and CRISPR Therapeutics Vertex and CRISPR Therapeutics entered into a strategic research collaboration in 2015 focused on the use of CRISPR/Cas9 to discover and develop potential new treatments aimed at the underlying genetic causes of human disease. Costs and profits worldwide are shared with CRISPR Therapeutics.

Medicine 111

Medicine Food and Drug Administration FDA Pharmaceutical 111

European Pharmaceutical Review

APRIL 29, 2024

This means that patients with the rare genetic bleeding disorder can produce FIX themselves instead of relying on regular intravenous infusions of FIX, which is the current standard of care, according to 2015 research highlighted by Pfizer.

Food and Drug Administration 96

Food and Drug Administration Medicine FDA Food 96

pharmaphorum

OCTOBER 29, 2015

Findings from the Veeva 2015 European Life Sciences Survey Is the industry getting what it needs? Customer data challenges are among the most vexing and pervasive that life sciences companies currently experience, especially with the increasing regulatory pressure and the transition to new business models they face.

Leads 52

Leads Marketing Pharma 52

European Pharmaceutical Review

JANUARY 9, 2024

The development of AI in and its application to the production process are all going to lead us into a new era where drugs are safer, more effective, and focused on treating patients. 2015; 13:8-17. 2015; 12(10):931-934. One of its most useful aspects is that answers to many questions come readily from data analysis.

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

pharmaphorum

JANUARY 9, 2023

is to acquire the 2015-established Amryt Pharma Plc. Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 Biopharma and healthcare group Chiesi Farmaceutici S.p.A. on 6 th January.

Pharma 98

Pharma Biopharma Management Medicine 98

European Pharmaceutical Review

APRIL 27, 2023

His contributions “have been integral in the evolution of our portfolio over the past several years, notably building our leading presence in immuno-oncology, growing our CV business and launching multiple new medicines,” Samuels added. Theodore R Samuels will continue to serve as Lead Independent Director.

Medicine 94

Medicine Marketing Government Leads 94

European Pharmaceutical Review

JANUARY 18, 2024

GlobalData’s Analyst covering Neurology and Ophthalmology, Thomas Parker, MPharmacol, predicted that Belsomra would lead the market by 2023. Comparatively, in 2015, GlobalData’s research expected that sales of therapies for Gaucher disease will reach $1.16 million in sales by 2032. billion by 2024.

Marketing 98

Marketing Sales Pharmacology Pharma 98

World of DTC Marketing

DECEMBER 10, 2020

In November 2017, a study published in JAMA Internal Medicine examined the costs of developing 10 cancer drugs approved by the FDA from 2006 to 2015 and provided a strong contrast to the Tufts study from a year before. It’s time for the Federal Government to negotiate drug prices directly with drug companies.

Insurance 181

Insurance Pharma Manufacturing Retail 181

European Pharmaceutical Review

AUGUST 26, 2022

Moderna claims that, when COVID-19 emerged, neither company had the same level of experience with “developing mRNA vaccines for infectious diseases” as Moderna, adding: “they knowingly followed Moderna’s lead in developing their own vaccine.”. ” But why sue now?

Sales 98

Sales Medicine Marketing Government 98

pharmaphorum

OCTOBER 7, 2022

BenevolentAI is a leading clinical-stage AI drug discovery company. The number of AI-based drug discovery strategic alliances has increased significantly in recent years: There were just 10 in 2015; in 2021, there were 105. By combining the power of AI with human expertise we are bringing new drug targets into our portfolio.”.

Sales 104

Sales Leads 104

European Pharmaceutical Review

JUNE 30, 2023

Since the 1990s, the annual harvest of Chinese horseshoe crab ( Tachypleus tridentatus ) for biomedical purposes has dropped from 600,000 to 100,000 in 2015, the paper noted. This conservation leads to a greater usage efficiency of the volume of reagent.

Manufacturing 98

Manufacturing Pharmaceutical Prospecting Leads 98

European Pharmaceutical Review

JANUARY 24, 2023

She was medical lead at SIBAmed GmbH for four years. At Parexel, Sandra held roles in Phase I project management and business development, before being promoted to a senior portfolio director in 2015. There, she oversaw clinical trials, including coordination, execution and regulatory processes.

Key account management 98

Key account management Physicians Networking Management 98

European Pharmaceutical Review

OCTOBER 7, 2022

In the years 2015 and 2020, clinical-stage cancer programmes increased by a considerable 77 percent (1,642 to 2,911), resulting in a quarter of drugs currently in development worldwide being highly potent. Leading companies in the oral solid dosage market are Catalent, Inc.,

Manufacturing 98

Manufacturing Marketing Side effects Transportation 98

pharmaphorum

AUGUST 17, 2022

The deal will see Atomwise identify, synthesize, and advance lead compounds for up to five drug targets that will then be exclusively Sanofi’s to develop. That same report noted that the number of companies in the AI drug discovery space increased tenfold between 2015 and 2021.

Medicine 97

Medicine Pharma Engineering Sales 97

pharmaphorum

OCTOBER 7, 2022

IQVIA has the long term market data, from World Reviews back to 1978, to investigate, and analysed nearly 30 years of launches into leading therapy classes, from multiple eras in the development of the pharmaceutical industry. Is this true?

Competition 95

Competition Marketing Medicine Pharmaceutical 95

Legacy MEDSearch

AUGUST 8, 2022

was established in China in 2015 and is a subsidiary of MicroPort Scientific Corporation. About MicroPort NaviBot MicroPort NaviBot International LLC was incorporated in 2020 and is headquartered in Foxborough, MA. NaviBot is subsidiary of MicroPort MedBot. About MicroPort MedBot Shanghai MicroPort MedBot (Group) Co.,

Food and Drug Administration 98

Food and Drug Administration Recruitment Medical Food 98

Sales Talent

FEBRUARY 7, 2020

As there isn’t a hiring forecast specific for b2b sales roles, we started our own forecast in 2015 to help fill this gap. This pressure is leading to increased base salaries. **The 2022 Sales Hiring Forecast has been released – check it out now!**. It’s time for the 6th installment of our annual sales hiring forecast.

Sales 130

Sales B2B Sales Recruitment Marketing 130

PM360

JULY 18, 2022

FINN Partners , an independent marketing and communications agency, is expanding its global footprint even further with the addition of SPAG , a leading, Asia-headquartered, health-sector communications and marketing firm with offices in Bangalore, Delhi, Indonesia, Malaysia, Mumbai, the Philippines, and Singapore.

Biopharma 96

Biopharma Management Marketing Leads 96

Clarivate

DECEMBER 8, 2021

Starting with 12,147 Research Fronts, representing papers published and cited between 2015 and 2020, the next step was to select the fronts containing core literature that is both highly cited and recent – a measure of particularly active and fast-moving research.

Specialization 98

Specialization Leads Government Medical 98

Pharmaceutical Technology

DECEMBER 6, 2022

The three leading Alzheimer’s disease (AD) drugs currently in development are all monoclonal antibodies—donanemab by Eli Lilly , lecanemab by Eisai and Biogen , and gantenerumab by Roche. AD currently affects more than 55 million people worldwide. Monoclonal antibodies make up half of these, with an 11% share of all AD approvals.

Marketing 59

Marketing Leads Pharmaceutical FDA 59

pharmaphorum

NOVEMBER 6, 2017

The Cancer Vanguard is a bold initiative setup to take leadership in the delivery of the National Cancer Strategy – Achieving World-Class Cancer Outcomes published in 2015 with a key aim of designing and implementing new and increasingly patient centric models of care in Cancer that can benefit and be adopted by the wider national cancer system.

Medicine 52

Medicine Pharma Patients Leads 52

European Pharmaceutical Review

JULY 25, 2022

According to the latest WHO estimates in 2015, this duped consumer base accounts for 50 percent of all online drug purchases. The growing complexity of supply chains – due to increased moving parts and geographies, faster lead times, limited visibility and greater product variability – creates havoc for anti-counterfeiting efforts.

Pharmaceutical 104

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 104

pharmaphorum

JULY 27, 2022

These values have seen a year-on-year decline since 2016 for exports and 2015 for imports, in contrast with a general upward trend seen in most comparator countries, said the ABPI. In 2020, exports were valued at $25.9bn, placing the UK ninth out of 20 countries, and imports at $26.8bn, meaning a ranking of tenth out of 20. R&D success.

Government 98

Government Recruitment Medicine Patients 98

PM360

NOVEMBER 29, 2022

In 2015, the United Nations launched 17 Sustainable Development Goals (SDGs) as part of the 2023 Agenda for Sustainable Development. Extreme temperatures lead to more cases of heat stroke, which can be fatal or lead to chronic health issues.

Healthcare 98

Healthcare Healthcare Manufacturing Pharmaceutical 98

Clarivate

SEPTEMBER 8, 2024

Generic RedCap technologies Nearly three-fourths of all core 5G patents are related to Generic RedCap technologies, with approximately 70% of these patents originating between 2015 and 2019. The leading six companies—Huawei, Samsung, Qualcomm, LG, Nokia and Ericsson —own nearly 64% of these patent families.

Distribution 52

Distribution Leads 52

pharmaphorum

SEPTEMBER 5, 2022

With funding from leading U.S. and Australian investors, Sam launched Kasada in 2015 to provide an innovative web traffic integrity solution to companies around the world. Sam Crowther is the founder and CEO of Kasada, a cybersecurity company specialising in stopping bot attacks. He is an entrepreneur with a passion for cybersecurity.

Prescription 138

Prescription Sales Distribution Doctors 138

pharmaphorum

SEPTEMBER 1, 2022

She was also a founder and chief scientific officer of UK biotech Heptares Therapeutics, maintaining that role after it was acquired by Japan’s Sosei in 2015, and held previous roles at Cambridge University, Millennium Pharma, and GSK. " This rings true today as I share news that I will step down as President of NIBR on Oct 31. .

Medicine 59

Medicine Biopharma Engineering Pharma 59

pharmaphorum

NOVEMBER 9, 2022

Where once whole blood or plasma transfusions were needed, now patients can receive recombinant, long-acting treatments that enable them to lead a life closer to normal. Lutz Bonacker joined CSL Behring in 2006 as Head of Global Commercial Development Coagulation and was promoted to his current position in 2015. About the author.

Management 98

Management Patients Sales goal Medical 98

Integrity Solutions

JULY 31, 2024

employees are either watching for or actively seeking a new job — the highest level since 2015. It can turn into a potentially self-defeating cycle that will inevitably lead to disengagement, burnout and turnover. The pandemic-era “Great Resignation” isn’t exactly behind us. Recent surveys show half of U.S.

Sales 171

Sales Management Training Product Knowledge 171

European Pharmaceutical Review

SEPTEMBER 20, 2023

Conversely, poor analytical characterisation will likely lead to questions from regulators and, without sufficient product and process knowledge, an IND or BLA that is eventually deemed incomplete. Incorrect DNA sequences can also lead to high levels of SVs. 2015; 7(5): 881-90. While SVs are typically present at less than 0.1

Patients 98

Patients Manufacturing Leads Safety 98

European Pharmaceutical Review

DECEMBER 21, 2022

Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure. During his time at Genentech Stefan has advanced several small molecules and new modalities (antibody‑drug conjugates, oligonucleotides and peptides) into the clinic as lead chemist and technical development leader.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

PM360

AUGUST 24, 2023

Today’s workforce includes Traditionalists (born 1927-1945), Boomers (1946-1964), Gen X (1965-1980), Millennials (1981-1996), and Gen Z (1997-2015). Marketing and comms teams that go beyond simply accepting generational differences by leveraging them proactively will lead to increased engagement, innovation, and organizational success.

Competition 98

Competition Marketing Healthcare Healthcare 98

European Pharmaceutical Review

AUGUST 23, 2022

It is also clear that this aspect will inevitably lead to discussions, but the principles on which the composition and activities of the Coordinators’ Group have been established open up a new frontier of political and scientific co-ordination within the EU Member States. effectiveness and therapeutic efficacy. About the authors.

Consulting 98

Consulting Medical Healthcare Healthcare 98

European Pharmaceutical Review

APRIL 11, 2024

Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. He leads Siemens’ efforts to optimise and improve processes for clients within the pharmaceutical, biopharmaceutical and medical device sectors. References Belkhir L, Elmeligi A.

Manufacturing 105

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 105